- DXCM has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $51.4 million.
- DXCM has traded 18,384 shares today.
- DXCM is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in DXCM with the Ticky from Trade-Ideas. See the FREE profile for DXCM NOW at Trade-Ideas More details on DXCM: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. Currently there are 10 analysts that rate DexCom a buy, 1 analyst rates it a sell, and 3 rate it a hold. The average volume for DexCom has been 599,800 shares per day over the past 30 days. DexCom has a market cap of $3.4 billion and is part of the health care sector and health services industry. The stock has a beta of 0.87 and a short float of 6.5% with 4.96 days to cover. Shares are up 43.8% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.